David Shaw’s Anterix ATEX Stock Holding History

David Shaw’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	+3,300	New	+$194K	﹤0.01%	4357

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

David Shaw's ATEX Position: Q2 2026 in Review

David Shaw increased its Anterix (ATEX) stake by 1,533% in Q2 2026, buying an estimated $5.12M and bringing the position to 92,990 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

David Shaw first reported a position in ATEX in Q2 2018 and has held it in 32 quarters since. The position peaked at $10.4M in Q3 2024. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

David Shaw held 92,990 shares of Anterix worth $9.57M as of Q2 2026.
David Shaw bought 87,294 Anterix shares in Q2 2026, an estimated $5.12M.
Anterix made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1847 holding.
David Shaw first reported a position in Anterix in Q2 2018 and has held it in 32 quarters since.
David Shaw's Anterix position peaked at $10.4M in Q3 2024.
171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.